Formation of a tissue-engineered cartilage structure based on decellularized cartilage microparticles in a perfusion bioreactor
https://doi.org/10.60043/2949-5938-2024-3-56-66
Abstract
The formation of a tissue equivalent based on injectable form of microdispersed scaffold — microparticles of decellularized porcine cartilage (DecCp) — seems to be a promising technology for repairing cartilage tissue defects. The aim of this work was to obtain and comparatively study a tissue-engineering construct (TEC) based on DecCp microparticles and mesenchymal stromal cells (MSCs) under static conditions and in perfusion bioreactor. Materials and methods. The decellularization process included freeze-thaw cycles (-196 °C...+37 °C), the use of surfactants (Triton X-100 and sodium dodecyl sulfate), as well as DNase treatment. The morphology of the surface and the nearest subsurface layer of the samples was studied using scanning electron microscopy. Each TEC consisted of 5×105 MSCs and 5 mg DecCp. Results. It was found that, compared with static conditions, the cultivation of MSCs on DecCp microparticles in a perfusion bioreactor for 14 days allows increasing the proliferative activity of cells with subsequent chondrogenic differentiation, as evidenced by the ability of the cellular component of cartilage to synthesize extracellular matrix (ECM), characteristic of cartilage tissue, histochemical analysis of which revealed the presence of collagen and glycosaminoglycans (GAG). Conclusion. The possibility of forming cartilage TECs based on DecCp and MSCs under 3D cultivation conditions both under static conditions and in a perfusion bioreactor was shown. Cultivation of MSCs on DecCp under flow conditions at a rate of 0.5 ml/min contributed to an increase in cell proliferative activity compared with static conditions, and also supported the ability of cells to synthesize ECM, characteristic of cartilage tissue, histochemical analysis of which revealed the presence of total collagen and GAG, which may be evidence of chondrogenic differentiation of MSCs.
About the Authors
Yulia B. BasokRussian Federation
Yulia B. Basok — Dr. Sci. (Biology), Head of the Department of Biomedical Technologies and Tissue Engineering Department,
123182, Shchukinskaya St., 1, Moscow.
Competing Interests:
The authors declare no conflict of interest.
Alexey M. Grigor’ev
Russian Federation
Alexey M. Grigor’ev — Cand. Sci. (Biology), Senior Researcher, Department of Biomedical Technologies and Tissue Engineering,
123182, Shchukinskaya St., 1, Moscow.
Competing Interests:
The authors declare no conflict of interest.
Liudmila A. Kirsanova
Russian Federation
Liudmila A. Kirsanova — Cand. Sci. (Biology), Senior Researcher, Department of Biomedical Technologies and Tissue Engineering,
123182, Shchukinskaya St., 1, Moscow.
Competing Interests:
The authors declare no conflict of interest.
Alexandra D. Belova
Russian Federation
Alexandra D. Belova — Cand. Sci. (Biology), Senior Researcher, Department of Biomedical Technologies and Tissue Engineering,
123182, Shchukinskaya St., 1, Moscow.
Competing Interests:
The authors declare no conflict of interest.
Anastasia M. Subbot
Russian Federation
Anastasia M. Subbot — MD, Cand. Sci. (Medicine), Head of the Laboratory of Fundamental Research in Ophthalmology,
119021, Rossolimo St., 11A, Moscow.
Competing Interests:
The authors declare no conflict of interest.
Ekaterina A. Guseva
Russian Federation
Ekaterina A. Guseva — Research Laboratory Assistant, Department of Biomedical Technologies and Tissue Engineering,
123182, Shchukinskaya St., 1, Moscow.
Competing Interests:
The authors declare no conflict of interest.
Evgeny A. Nemets
Russian Federation
Evgeny A. Nemets — Dr. Sci. (Biology), Leading Researcher, Department of Biomedical Technologies and Tissue Engineering,
123182, Shchukinskaya St., 1, Moscow.
Competing Interests:
The authors declare no conflict of interest.
V. I. Sevastianov
Russian Federation
Victor I. Sevastianov — Dr. Sci. (Biology), Professor of Biophysics, Senior Specialist, Department of Scientific and Medical Personnel Training; Head,
123182, Shchukinskaya St., 1, Moscow;
123557, Bol’shoj Tishinskij pereulok, 43/20, str. 2, Moscow.
Competing Interests:
The authors declare no conflict of interest.
References
1. Alcaide-Ruggiero L, Molina-Hernández V, Granados MM, Domínguez JM. Main and Minor Types of Collagens in the Articular Cartilage: The Role of Collagens in Repair Tissue Evaluation in Chondral Defects. Int J Mol Sci. 2021;22(24):13329. DOI: 10.3390/ijms222413329
2. Almonte-Becerril M, Navarro-Garcia F, Gonzalez-Robles A, Vega-Lopez MA, Lavalle C, Kouri JB. Cell death of chondrocytes is a combination between apoptosis and autophagy during the pathogenesis of Osteoarthritis within an experimental model. Apoptosis. 2010;15(5):631–638. DOI: 10.1007/s10495-010-0458-z
3. Suh DS, Yoo JC, Woo SH, Kwak AS. Intra-Articular Atelocollagen Injection for the Treatment of Articular Cartilage Defects in Rabbit Model. Tissue Eng Regen Med. 2021;18(4):663–670. DOI: 10.1007/s13770-021-00337-0
4. Lian C, Wang X, Qiu X, Wu Z, Gao B, Liu L, et al. Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1-SMAD1 interaction. Bone Res. 2019;7:8. DOI: 10.1038/s41413-019-0046-y
5. Carneiro DC, Araújo LT, Santos GC, Damasceno PKF, Vieira JL, Santos RRD, et al. Clinical Trials with Mesenchymal Stem Cell Therapies for Osteoarthritis: Challenges in the Regeneration of Articular Cartilage. Int J Mol Sci. 2023;24(12):9939. DOI: 10.3390/ijms24129939
6. Song Y, Jorgensen C. Mesenchymal Stromal Cells in Osteoarthritis: Evidence for Structural Benefit and Cartilage Repair. Biomedicines. 2022;10(6):1278. DOI: 10.3390/biomedicines10061278
7. Lam ATL, Reuveny S, Oh SK. Human mesenchymal stem cell therapy for cartilage repair: Review on isolation, expansion, and constructs. Stem Cell Res. 2020;44:101738. DOI: 10.1016/j.scr.2020.101738
8. Nemets EA, Lazhko AE, Basok YB, Kirsanova LA, Kirillova AD, Sevastianov VI. Preparation of Tissue-Specific Matrix from Decellularized Porcine Cartilage. Russian Journal of Physical Chemistry B. 2020;14(8):1245–1251. DOI: 10.1134/S1990793120080059
9. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011;32(12):3233–3243. DOI: 10.1016/j.biomaterials.2011.01.057
10. Reina-Mahecha A, Beers MJ, van der Veen HC, Zuhorn IS, van Kooten TG, Sharma PK. A Review of the Role of Bioreactors for iPSCs-Based Tissue-Engineered Articular Cartilage. Tissue Eng Regen Med. 2023;20(7):1041–1052. DOI: 10.1007/s13770-023-00573-6
11. Ravichandran A, Liu Y, Teoh SH. Review: bioreactor design towards generation of relevant engineered tissues: focus on clinical translation. J Tissue Eng Regen Med. 2018;12(1):e7– e22. DOI: 10.1002/term.2270
12. Aprile P, Kelly DJ. Hydrostatic Pressure Regulates the Volume, Aggregation and Chondrogenic Differentiation of Bone Marrow Derived Stromal Cells. Front Bioeng Biotechnol. 2021;15:8:619914. DOI: 10.3389/fbioe.2020.619914
13. Sevastianov VI, Basok YB, Grigoriev AM, Nemets EA, Kirillova AD, Kirsanova LA, et al. Decellularization of cartilage microparticles: Effects of temperature, supercritical carbon dioxide and ultrasound on biochemical, mechanical, and biological properties. J Biomed Mater Res A. 2023;111(4):543–555. DOI: 10.1002/jbm.a.37474
14. Севастьянов ВИ, Басок ЮБ, Григорьев АМ, Кирсанова ЛА, Василец ВН. Применение технологии тканевой инженерии для формирования хрящевой ткани человека в проточном биореакторе. Вестник трансплантологии и искусственных органов. 2017;19(3):81–92. DOI: 10.15825/1995-1191-2017-3-81-92
15. Theodoridis K, Aggelidou E, Manthou M, Demiri E, Bakopoulou A, Kritis A. Assessment of cartilage regeneration on 3D collagen-polycaprolactone scaffolds: evaluation of growth media in static and in perfusion bioreactor dynamic culture. Colloids Surf B Biointerfaces. 2019;183:110403. DOI: 10.1016/j.colsurfb.2019.110403
16. Kock LM, Malda J, Dhert WJ, Ito K, Gawlitta D. Flow-perfusion interferes with chondrogenic and hypertrophic matrix production by mesenchymal stem cells. J Biomech. 2014;47(9):2122–2129. DOI: 10.1016/j.jbiomech.2013.11.006
17. Schulz RM, Wüstneck N, van Donkelaar CC, Shelton JC, Bader A. Development and validation of a novel bioreactor system for load- and perfusion-controlled tissue engineering of chondrocyte-constructs. Biotechnol Bioeng. 2008;101(4):714–728. DOI: 10.1002/bit.21955
18. Tiğli RS, Cannizaro C, Gümüşderelioğlu M, Kaplan DL. Chondrogenesis in perfusion bioreactors using porous silk scaffolds and hESC-derived MSCs. J Biomed Mater Res A. 2011;96(1):21–28. DOI: 10.1002/jbm.a.32949
19. Nazempour A, Quisenberry CR, Abu-Lail NI, Van Wie BJ. Combined effects of oscillating hydrostatic pressure, perfusion and encapsulation in a novel bioreactor for enhancing extracellular matrix synthesis by bovine chondrocytes. Cell Tissue Res. 2017;370(1):179–193. DOI: 10.1007/s00441-017-2651-7
20. Silva JC, Moura CS, Borrecho G, et al. Extruded Bioreactor Perfusion Culture Supports the Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells in 3D Porous Poly(ɛ-Caprolactone) Scaffolds. Biotechnol J. 2020;15(2):e1900078. DOI: 10.1002/biot.201900078
Review
For citations:
Basok Yu.B., Grigor’ev A.M., Kirsanova L.A., Belova A.D., Subbot A.M., Guseva E.A., Nemets E.A., Sevastianov V.I. Formation of a tissue-engineered cartilage structure based on decellularized cartilage microparticles in a perfusion bioreactor. Регенерация органов и тканей. 2024;2(3):56-66. (In Russ.) https://doi.org/10.60043/2949-5938-2024-3-56-66